Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZLAB · against 1,335 other Healthcare companies
Ranked #1,116 of 1,336 · scores higher than 16% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 10–19, including ZLAB · Click a bar to see the companies
Mainly because of its return on invested capital, operating margin and return on assets, which are weaker than most Healthcare peers.
| Metric | ZLAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -104.7% | 4.7% | 7% | 33% | |
| Operating marginHigher is better · 1,251 reported | -58.7% | 7.1% | 16% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -17.5% | 1.7% | 21% | 33% | |
| Return on equityHigher is better · 1,252 reported | -26.9% | 3.2% | 23% | Context only | |
| Gross marginHigher is better · 1,394 reported | 3.8% | 45.9% | 16% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 1,116 | 643M USD | 16 | 31 | |
| 1,116 | 1.6B USD | 16 | 24 | |
| 1,116 | 6.0B USD | 16 | 32 | |
| 1,116 | 1.5B USD | 16 | 39 | |
| 1,116 | 2.5B USD | 16 | 31 | |
| 1,130 | 115M USD | 15 | 8 | |
| 1,130 | 16.5B USD | 15 | 37 | |
| 1,130 | 642M USD | 15 | 46 | |
| 1,130 | 1.7B USD | 15 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score